Citation Impact
Citing Papers
Acute Phase Proteins with Special Reference to C-Reactive Protein and Related Proteins (Pentaxins) and Serum Amyloid A Protein
1983 Standout
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
2013 Standout
Cutting Edge: KIR Antisense Transcripts Are Processed into a 28-Base PIWI-Like RNA in Human NK Cells
2010
Plasma β-amyloid in Alzheimer’s disease and vascular disease
2016 StandoutNobel
Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice
2015
Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future
2004
Impact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels
2008
Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy
2009
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
2016 StandoutNature
Killer immunoglobulin-like receptors
2004
The Amyloid-β Pathway in Alzheimer’s Disease
2021
An Apolipoprotein E-Mimetic Stimulates Axonal Regeneration and Remyelination after Peripheral Nerve Injury
2010
Spinal Infections
2006
Necroptosis and its role in inflammation
2015 StandoutNature
Rheumatoid arthritis
2016 Standout
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Microglial low-density lipoprotein receptor-related protein 1 modulates c-Jun N-terminal kinase activation
2009
Recognition of microorganisms and activation of the immune response
2007 StandoutNature
Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial
1999 Standout
Complement activation and choriocapillaris loss in early AMD: Implications for pathophysiology and therapy
2014
C-reactive protein: a critical update
2003 Standout
Human cytolytic T lymphocytes expressing HLA class-I-specific inhibitory receptors
2005
Macular degeneration: recent advances and therapeutic opportunities
2006
Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis
2004 Standout
A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease
1997 Standout
The Pathogenesis of Rheumatoid Arthritis
2011 Standout
Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis
1995 Standout
The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.
1998 Standout
TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease Model
2015 Standout
Age-related macular degeneration
2012 Standout
Glycans in cancer and inflammation — potential for therapeutics and diagnostics
2005 StandoutNobel
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
Association of Fibrinogen, C-reactive Protein, Albumin, or Leukocyte Count With Coronary Heart Disease
1998 Standout
Self-assembling peptide nanofiber scaffold promotes the reconstruction of acutely injured brain
2009
Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases
2007 Standout
ApoE deficiency leads to a progressive age-dependent blood-brain barrier leakage
2006
Vascular endothelial growth factor in eye disease
2008 Standout
Development, maintenance and disruption of the blood-brain barrier
2013 Standout
Genetic inactivation of adenosine A2A receptors attenuates acute traumatic brain injury in the mouse cortical impact model
2008
The regulation of lymphocyte activation by inhibitory receptors
2004
Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity
2012 Standout
Age-related macular degeneration
2018 Standout
Geographic Atrophy
2014
Apolipoprotein E in Alzheimer's disease and other neurological disorders
2011
Alzheimer's disease
2016 Standout
Adult Neurogenesis in the Mammalian Brain: Significant Answers and Significant Questions
2011 Standout
Reducing Human Apolipoprotein E Levels Attenuates Age-Dependent Aβ Accumulation in Mutant Human Amyloid Precursor Protein Transgenic Mice
2012
Neuronal hyperactivity due to loss of inhibitory tone in APOE4 mice lacking Alzheimer’s disease-like pathology
2017
Non-coding RNAs in human disease
2011 Standout
Molecular pathology of age-related macular degeneration
2008
Aging, age-related macular degeneration, and the response-to-retention of apolipoprotein B-containing lipoproteins
2009
Vertebral Osteomyelitis
2010 Standout
The Role of Apolipoprotein E in Alzheimer's Disease
2009
A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis
2000 Standout
The blockade of immune checkpoints in cancer immunotherapy
2012 Standout
Rheumatoid arthritis
2010 Standout
Distinct contribution of IL-6, TNF-α, IL-1, and IL-10 to T cell–mediated spontaneous autoimmune arthritis in mice
2004 StandoutNobel
ApoE4 Decreases Spine Density and Dendritic Complexity in Cortical NeuronsIn Vivo
2009
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Anti-perinuclear factor compared with the so called “antikeratin” antibodies and antibodies to human epidermis filaggrin, in the diagnosis of arthritides
1999
Apolipoprotein E as a Therapeutic Target in Alzheimer’s Disease: A Review of Basic Research and Clinical Evidence
2016
Apolipoprotein E controls cerebrovascular integrity via cyclophilin A
2012 Nature
Metabolic selection of glycosylation defects in human cells
2001 StandoutNobel
Postmortem Delay Has Minimal Effect on Brain RNA Integrity
2007
The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina
1994 Standout
Apolipoprotein E4 Causes Age- and Tau-Dependent Impairment of GABAergic Interneurons, Leading to Learning and Memory Deficits in Mice
2010
Programmed necrosis, not apoptosis, is a key mediator of cell loss and DAMP-mediated inflammation in dsRNA-induced retinal degeneration
2013
Lysosome-targeting chimaeras for degradation of extracellular proteins
2020 StandoutNatureNobel
GABAergic Interneuron Dysfunction Impairs Hippocampal Neurogenesis in Adult Apolipoprotein E4 Knockin Mice
2009
Low‐density lipoprotein receptors regulate microglial inflammation through c‐Jun N‐terminal kinase
2008
Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α
1993
MHC class I molecules and kirs in human history, health and survival
2005
Apolipoprotein E-Derived Peptides Ameliorate Clinical Disability and Inflammatory Infiltrates into the Spinal Cord in a Murine Model of Multiple Sclerosis
2006
Dysregulated autophagy in the RPE is associated with increased susceptibility to oxidative stress and AMD
2014
Interleukin-10 and interleukin-6 in lupus erythematosus and rheumatoid arthritis, correlations with acute phase proteins
1997
Emergence of a seizure phenotype in aged apolipoprotein epsilon 4 targeted replacement mice
2012
Interleukin‐6 receptor inhibition with tocilizumab and attainment of disease remission in rheumatoid arthritis: The role of acute‐phase reactants
2010
Glycoforms of serum ?1-acid glycoprotein as markers of inflammation and cancer
1995
The Simplified Disease Activity Index and Clinical Disease Activity Index to Monitor Patients in Standard Clinical Care
2009
Latest Advances in Understanding Preeclampsia
2005 StandoutScience
NK CELL RECOGNITION
2004 Standout
The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity
2009 Standout
Associations Between Age-Related Macular Degeneration, Alzheimer Disease, and Dementia
2013
Lecanemab in Early Alzheimer’s Disease
2022 Standout
Individual relationship between progression of radiological damage and the acute phase response in early rheumatoid arthritis. Towards development of a decision support system.
1997
Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis.
1992
Different and Divergent Regulation of the KIR2DL4 and KIR3DL1 Promoters
2003
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
2015 Standout
Transcriptional neoteny in the human brain
2009 StandoutNobel
Impact of β2 integrin deficiency on mouse natural killer cell development and function
2011 StandoutNobel
Therapeutic Glucocorticoid-Induced TNF Receptor-Mediated Amplification of CD4+ T Cell Responses Enhances Antiparasitic Immunity
2010 StandoutNobel
The Protein Made from a Common Allele of KIR3DL1 (3DL1*004) Is Poorly Expressed at Cell Surfaces due to Substitution at Positions 86 in Ig Domain 0 and 182 in Ig Domain 1
2003
KIR: Diverse, Rapidly Evolving Receptors of Innate and Adaptive Immunity
2002
Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2
2001
Dendritic cell maturation by innate lymphocytes
2005 StandoutNobel
Interleukin-10 and the Interleukin-10 Receptor
2001 Standout
Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation
1997 Standout
Association of HLA antigens, toxic reactions and therapeutic response to auranofin and aurothioglucose in patients with rheumatoid arthritis
1983
Human natural killer cells
2008
Dietary fat and the risk of age-related maculopathy: the POLANUT Study.: Dietary fat and ARM
2007
Distinct contribution of IL-6, TNF-α, IL-1, and IL-10 to T cell–mediated spontaneous autoimmune arthritis in mice
2004 StandoutNobel
Meta-analysis of APOE genotype and subarachnoid hemorrhage
2007
APOE ε4: The most prevalent yet understudied risk factor for Alzheimer's disease
2014
KIR2DL4 (CD158d) Genotype Influences Expression and Function in NK Cells
2003
ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling
2010
Innate or Adaptive Immunity? The Example of Natural Killer Cells
2011 StandoutScience
SOD2 Knockdown Mouse Model of Early AMD
2007
Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis.
1994
Works of Brian E. Mace being referenced
Simvastatin and atorvastatin improve behavioral outcome, reduce hippocampal degeneration, and improve cerebral blood flow after experimental traumatic brain injury
2007
Reduced levels of human apoE4 protein in an animal model of cognitive impairment
2009
Altered neurotransmission in the lateral amygdala in aged human apoE4 targeted replacement mice
2014
Human Apolipoprotein E4 Targeted Replacement Mice Show Increased Prevalence of Intracerebral Hemorrhage Associated with Vascular Amyloid Deposition
2008
Targeting age-related macular degeneration with Alzheimer’s disease based immunotherapies: Anti-amyloid-β antibody attenuates pathologies in an age-related macular degeneration mouse model
2007
Progressive loss of synaptic integrity in human apolipoprotein E4 targeted replacement mice and attenuation by apolipoprotein E2
2010
Marked regional differences of brain human apolipoprotein e expression in targeted replacement mice
2004
Human apoE4-targeted replacement mice display synaptic deficits in the absence of neuropathology
2005
Mortalin is regulated by APOE in hippocampus of AD patients and by human APOE in TR mice
2006
Apolipoprotein E modifies the CNS response to injury via a histamine-mediated pathway
2007
Traumatic Brain Injury Exacerbates Neurodegenerative Pathology: Improvement with an Apolipoprotein E-Based Therapeutic
2010
Correlation of clinical parameters of disease activity in rheumatoid arthritis with serum concentration of C-reactive protein and erythrocyte sedimentation rate.
1982
A novel therapeutic derived from apolipoprotein E reduces brain inflammation and improves outcome after closed head injury
2005
Apolipoprotein E allele-dependent pathogenesis: A model for age-related retinal degeneration
2005
Anti-keratin antibodies in rheumatoid arthritis: frequency and correlation with other features of the disease.
1983
Anti-amyloid therapy protects against retinal pigmented epithelium damage and vision loss in a model of age-related macular degeneration
2011
Bw4-reactive and Bw6-reactive antibodies recognize multiple distinct HLA structures that partially overlap in the alpha-1 helix.
1994
DNA Methylation Maintains Allele-specific KIR Gene Expression in Human Natural Killer Cells
2003
THE ASSESSMENT OF DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS USING A MULTIVARIATE ANALYSIS
1981